Iodide

Iodide

SCHEMBL7424045

I.N=C(N)c1ccc(Cn2c(C(=O)O)cc3ccccc32)cc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.71
F10 P00742 11/20 0.70
PLA2G10 O15496 1/20 0.58
F2 P00734 1/20 0.56
GPR35 Q9HC97 1/20 0.52
PLAU P00749 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6432819 0.86 F10 (0.84) CCR2F10PLA2G10F2
SCHEMBL27513366 0.86 CCR2 (0.72) CCR2F10PLA2G10GPR35
SCHEMBL25017563 0.84 F10 (0.60) CCR2F10PLA2G10F2
SCHEMBL5378162 0.84 CCR2 (1.00) CCR2F10PLA2G10GPR35
Hydrochloric Acid SCHEMBL6434172 0.83 F10 (0.85) F10F2
SCHEMBL6436953 0.82 F10 (1.00) CCR2F10F2
Hydrochloric Acid SCHEMBL6436952 0.82 F10 (0.98) CCR2F10F2
SCHEMBL3961949 0.81 CCR2 (1.00) CCR2GPR35
SCHEMBL29845455 0.80 CCR2 (0.81) CCR2F10PLA2G10GPR35
SCHEMBL7008246 0.80 CCR2 (0.81) CCR2PLA2G10GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6337344-B1 ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-08 US disclosed
EP-1042287-A1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA Aventis Pharma Deutschland GmbH (DE) 2000-10-11 EP disclosed
WO-1999033800-A1 INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-08 WO disclosed